Health News

Empowering Women to Fight Heart Disease
Heart disease in the No. 1 killer of women — causing more deaths than all forms of cancer combined. That's why the American Heart Association's Go Red for Women movement is coming to cities across the US.
Getting a Handle on Hypertension
If a condition causes no visible symptoms, it can seem easy enough to ignore it. But experts stress that out of sight, out of mind could spell trouble when it comes to high blood pressure.
What Arts, Crafts and Computer Use Might Do for Your Mind
Book clubs, painting classes and computer games are just a few fun ways to spend retirement. And such mind-engaging activities may also do wonders for older people's mental health.
How Pesticides May Heighten Heart Risks
In the 1970s, the pesticide DDT was banned in the US and many other countries. Its effects, however, may linger on. To this day, pesticide exposure may increase heart health risks.
Hepatitis C Treatment Granted Breakthrough Designation
KENILWORTH, N.J.--(BUSINESS WIRE)-- Merck (NYSE:MRK), known as MSD outside of the United States and Canada, today announced that grazoprevir/elbasvir, an investigational single tablet regimen for the treatment of chronic hepatitis C virus (HCV) infection, has received two new Breakthrough Therapy designations from the U.S. Food and Drug Administration (FDA) for the treatment of patients with chronic HCV genotype 4 (GT4) infection, and for the treatment of chronic HCV genotype 1 (GT1) infection in patients with end stage renal disease on hemodialysis. Additionally, the company announced presen...
Blue Bell Expands Ice Cream Recall
FOR IMMEDIATE RELEASE — April 7, 2015 — Brenham, TX — Blue Bell Creameries is expanding its recall of products that were produced in the Broken Arrow, Okla., plant to include Banana Pudding Ice Cream pints which tested positive for Listeria monocytogenes, and additional products manufactured on the same line.
5 Things to Know About SIDS
Learn the facts about SIDS to help protect your infant through his or her first year. 
Progress in the Fight Against Cancer
The fight against cancer is ongoing, but the newest numbers offer a bit of good news.
New Down Syndrome Test: More Accurate, More Limited
A new test might improve the accuracy of Down syndrome diagnoses.
Ovarian Cancer Rx Receives Breakthrough Therapy Designation
BOULDER, Colo.--(BUSINESS WIRE)--Apr. 6, 2015-- Clovis Oncology, Inc. (NASDAQ: CLVS) announced today that the U.S. Food and Drug Administration (FDA) has granted Breakthrough Therapy designation for the Company’s investigational agent rucaparib as monotherapy treatment of advanced ovarian cancer in patients who have received at least two lines of prior platinum-containing therapy, with BRCA-mutated tumors, inclusive of both germline BRCA (gBRCA) and somatic BRCA (sBRCA) mutations.